Craniosacral Therapy for the Treatment of Chronic Neck Pain: A Randomized Sham-controlled Trial

• Published in: The Clinical journal of pain Vol. 32; no. 5; p. 441
• Main Authors: Haller, Heidemarie, Lauche, Romy, Cramer, Holger, Rampp, Thomas, Saha, Felix J, Ostermann, Thomas, Dobos, Gustav
• Format: Journal Article
• Language: English
• Published: United States 01.05.2016
• Subjects: Adult; Aged; Chronic Pain - rehabilitation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Musculoskeletal Manipulations - methods; Neck Pain - psychology; Neck Pain - rehabilitation; Outcome Assessment (Health Care); Pain Measurement; Single-Blind Method; Treatment Outcome; Young Adult
• ISSN: 1536-5409
• DOI: 10.1097/AJP.0000000000000290

With growing evidence for the effectiveness of craniosacral therapy (CST) for pain management, the efficacy of CST remains unclear. This study therefore aimed at investigating CST in comparison with sham treatment in chronic nonspecific neck pain patients. A total of 54 blinded patients were randomized into either 8 weekly units of CST or light-touch sham treatment. Outcomes were assessed before and after treatment (week 8) and again 3 months later (week 20). The primary outcome was the pain intensity on a visual analog scale at week 8; secondary outcomes included pain on movement, pressure pain sensitivity, functional disability, health-related quality of life, well-being, anxiety, depression, stress perception, pain acceptance, body awareness, patients' global impression of improvement, and safety. In comparison with sham, CST patients reported significant and clinically relevant effects on pain intensity at week 8 (-21 mm group difference; 95% confidence interval, -32.6 to -9.4; P=0.001; d=1.02) and at week 20 (-16.8 mm group difference; 95% confidence interval, -27.5 to -6.1; P=0.003; d=0.88). Minimal clinically important differences in pain intensity at week 20 were reported by 78% within the CST group, whereas 48% even had substantial clinical benefit. Significant between-group differences at week 20 were also found for pain on movement, functional disability, physical quality of life, anxiety and patients' global improvement. Pressure pain sensitivity and body awareness were significantly improved only at week 8. No serious adverse events were reported. CST was both specifically effective and safe in reducing neck pain intensity and may improve functional disability and the quality of life up to 3 months after intervention.